FDA Approves Sub-q Tx for Multiple Myeloma – Tecvayli
Whoa….. we missed covering this FDA approval. Way back in October the FDA approved a new subcutaneous treatment, Tecvayli from Janssen Biotech, for adult patients
December 16, 2022
Whoa….. we missed covering this FDA approval. Way back in October the FDA approved a new subcutaneous treatment, Tecvayli from Janssen Biotech, for adult patients
In the spirit of continuing to elevate our client offerings, services and experiences Anton Health is proud to welcome Tara Mautone as the Executive Director
Optum is turning to technology to bring down special infusion spend. Others have tried a variety of ideas to achieve this goal going back to the
It has finally happened….. the decades’ long wait for the approval of the holy grail in hemophilia treatment….. a gene therapy that replaces the need for
The FDA recently approved a new infused therapy, Elahere (mirvetuximab soravtansine-gynx) from ImmunoGen Inc., indicated for the treatment of adult patients with folate receptor alpha
One of the few 2022 specialty pharmacy acquisitions was announced recently. Elevance Health will acquire long running BioPlus as it seeks to expand its specialty
There is a general understanding that Big Pharma spent a lot of effort and $$$s to counter-detail legislation to allow price negotiations in Medicare. They viewed
We’ve often written about companies that work with hospitals to develop owned-and-operated specialty pharmacies. Those pharmacies boast that they that are significantly better than independent
Walgreens….. its been good to know ya! That’s not saying that Walgreens is going away. To the contrary, it is the dawn of a new day
The FDA recently approved a new first-in-class tyrosine kinase 2 (Tyk2) inhibitor, ORAL therapy, Sotyktu (deucravacitinib) from Bristol Myers Squibb, for the treatment of adults
